Langley, Paul C. 2017. “Rush to Judgement: Imaginary Worlds and Cost-Outcomes Claims for PCSK9 Inhibitors”. INNOVATIONS in Pharmacy 8 (2). https://doi.org/10.24926/iip.v8i2.516.